Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Michael J. Flister PhD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Physiology

Member of the Cancer Center
Member of the Cardiovascular Center


  • Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. (Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A) Breast Cancer Res Treat 2017 Aug;165(1):53-64 PMID: 28567545 06/02/2017
  • MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma. (Olasz EB, Seline LN, Schock AM, Duncan NE, Lopez A, Lazar J, Flister MJ, Lu Y, Liu P, Sokumbi O, Harwood CA, Proby CM, Neuburg M, Lazarova Z) PLoS One 2015;10(5):e0125412 PMID: 25938461 PMCID: PMC4418692 05/06/2015
  • 2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular Research. (Flister MJ, Prokop JW, Lazar J, Shimoyama M, Dwinell M, Geurts A, International Committee on Standardized Genetic Nomenclature for Mice, Rat Genome and Nomenclature Committee) J Cardiovasc Transl Res 2015 Jun;8(4):269-77 PMID: 25920443 PMCID: PMC4475456 04/30/2015
  • SH2B3 Is a Genetic Determinant of Cardiac Inflammation and Fibrosis. (Flister MJ, Hoffman MJ, Lemke A, Prisco SZ, Rudemiller N, O'Meara CC, Tsaih SW, Moreno C, Geurts AM, Lazar J, Adhikari N, Hall JL, Jacob HJ) Circ Cardiovasc Genet 2015 Apr;8(2):294-304 PMID: 25628389 01/30/2015
  • Vascular dysfunction precedes hypertension associated with a blood pressure locus on rat chromosome 12. (Prisco SZ, Priestley JR, Weinberg BD, Prisco AR, Hoffman MJ, Jacob HJ, Flister MJ, Lombard JH, Lazar J) Am J Physiol Heart Circ Physiol 2014 Oct 15;307(8):H1103-10 PMID: 25320330 PMCID: PMC4200336 10/17/2014
  • Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity. (Yeo NC, O'Meara CC, Bonomo JA, Veth KN, Tomar R, Flister MJ, Drummond IA, Bowden DW, Freedman BI, Lazar J, Link BA, Jacob HJ) Genome Res 2015 Jan;25(1):57-65 PMID: 25273069 PMCID: PMC4317173 10/03/2014
  • CXM: a new tool for mapping breast cancer risk in the tumor microenvironment. (Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ) Cancer Res 2014 Nov 15;74(22):6419-29 PMID: 25172839 PMCID: PMC4247541 08/31/2014
  • Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat. (Endres BT, Priestley JR, Palygin O, Flister MJ, Hoffman MJ, Weinberg BD, Grzybowski M, Lombard JH, Staruschenko A, Moreno C, Jacob HJ, Geurts AM) Proc Natl Acad Sci U S A 2014 Sep 02;111(35):12817-22 PMID: 25136115 PMCID: PMC4156702 08/20/2014
  • Refined mapping of a hypertension susceptibility locus on rat chromosome 12. (Prisco SZ, Prokop JW, Sarkis AB, Yeo NC, Hoffman MJ, Hansen CC, Jacob HJ, Flister MJ, Lazar J) Hypertension 2014 Oct;64(4):883-90 PMID: 25001272 PMCID: PMC4162822 07/09/2014
  • Identifying multiple causative genes at a single GWAS locus. (Flister MJ, Tsaih SW, O'Meara CC, Endres B, Hoffman MJ, Geurts AM, Dwinell MR, Lazar J, Jacob HJ, Moreno C) Genome Res 2013 Dec;23(12):1996-2002 PMID: 24006081 PMCID: PMC3847770 09/06/2013
  • Female-specific hypertension loci on rat chromosome 13. (Hoffman MJ, Flister MJ, Nunez L, Xiao B, Greene AS, Jacob HJ, Moreno C) Hypertension 2013 Sep;62(3):557-63 PMID: 23817491 PMCID: PMC3870583 07/03/2013
  • Congenic mapping and sequence analysis of the Renin locus. (Flister MJ, Hoffman MJ, Reddy P, Jacob HJ, Moreno C) Hypertension 2013 Apr;61(4):850-6 PMID: 23460292 PMCID: PMC3770301 03/06/2013
  • Identification of hypertension susceptibility loci on rat chromosome 12. (Flister MJ, Prisco SZ, Sarkis AB, O'Meara CC, Hoffman M, Wendt-Andrae J, Moreno C, Lazar J, Jacob HJ) Hypertension 2012 Oct;60(4):942-8 PMID: 22868394 PMCID: PMC3873777 08/08/2012
  • New model of macrophage acquisition of the lymphatic endothelial phenotype. (Hall KL, Volk-Draper LD, Flister MJ, Ran S) PLoS One 2012;7(3):e31794 PMID: 22396739 PMCID: PMC3292559 03/08/2012
  • Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases. (Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S) Neoplasia 2011 Apr;13(4):327-38 PMID: 21472137 PMCID: PMC3071081 04/08/2011
  • Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB. (Flister MJ, Volk LD, Ran S) Microcirculation 2011 Feb;18(2):85-101 PMID: 21166921 PMCID: PMC3058545 12/21/2010
  • Lymphangiogenesis and lymphatic metastasis in breast cancer. (Ran S, Volk L, Hall K, Flister MJ) Pathophysiology 2010 Sep;17(4):229-51 PMID: 20036110 PMCID: PMC2891887 12/29/2009
  • Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. (Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S) Blood 2010 Jan 14;115(2):418-29 PMID: 19901262 PMCID: PMC2808162 11/11/2009
  • Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy. (Volk LD, Flister MJ, Bivens CM, Stutzman A, Desai N, Trieu V, Ran S) Neoplasia 2008 Jun;10(6):613-23 PMID: 18516298 PMCID: PMC2386546 06/03/2008
  • Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model. (Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S) Int J Cancer 2007 Nov 15;121(10):2181-91 PMID: 17597103 06/29/2007
  • Last update: 10/02/2017
    jenkins-FCD Prod-164 dfc08cb8c9ba6489ef52627ede450784778aa7cb